[Edaily Reporter Shin Ha-yeon ] JEONJINBIO CO., LTD.(110020)announced on the 22nd that it is expanding the supply of its new home care product line to target the global market.
The company recently finalized a deal to supply new home care products to a global distribution firm with annual revenue of 2 trillion won on a consolidated basis, both domestically and internationally. These products, which form a new home care line following the company’s existing flagship item—capsule detergent—are scheduled to be supplied to domestic and international distribution networks after passing quality verification by the global client. A view of JEONJINBIO CO., LTD.’s headquarters. (Photo: JEONJINBIO CO., LTD.) JEONJINBIO CO., LTD. plans to use this supply agreement as an opportunity to increase the proportion of overseas sales in its home care business and strengthen cooperation with global partners. The company intends to leverage its partners’ global distribution networks to increase market share while simultaneously pursuing revenue growth and improved profitability in this business segment.
JEONJINBIO CO., LTD. official stated, “Following our existing capsule detergents, our new home care products also meet the strict standards of our global partners, allowing us to expand our supply contracts,” adding, “Based on our sales network and technological capabilities, we will continuously increase overseas supply volumes to cultivate the home care business as a core growth engine.”
“Now, when structuring a deal, we must consider not only whether the structure is legally feasible, but also whether we can explain it in a way that allows us to defend it before the board of director…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Regulatory authorities in South Korea and the United States have reached differing conclusions regarding “JointStem,” a stem cell therapy for degenerative knee osteoarthritis developed by NATURECELL C…